Showing results (501-510 of 5,981) with videos related to

Sort By:
Pageof 599
Molecular Psychiatry|July 10, 2003
Reduced brain-derived neurotrophic factor in prefrontal cortex of patients with schizophreniaC S Weickert, T M Hyde, B K Lipska, et al.
Molecular Psychiatry|July 10, 2003
Dense linkage disequilibrium mapping in the 15q11-q13 maternal expression domain yields evidence for association in autismE L Nurmi, T Amin, L M Olson, et al.
Molecular Psychiatry|July 10, 2003
Genetic association of acyl-coenzyme A: cholesterol acyltransferase with cerebrospinal fluid cholesterol levels, brain amyloid load, and risk for Alzheimer's diseaseM A Wollmer, J R Streffer, M Tsolaki, et al.
Molecular Psychiatry|July 10, 2001
Proposed endophenotypes of dysthymia: evolutionary, clinical and pharmacogenomic considerationsA B Niculescu, H S Akiskal
Molecular Psychiatry|July 10, 2001
RNA editing of the 5-HT(2C) receptor is reduced in schizophreniaM S Sodhi, P W Burnet, A J Makoff, et al.
Molecular Psychiatry|July 10, 2001
D10S1423 identifies a susceptibility locus for Alzheimer's disease in a prospective, longitudinal, double-blind study of asymptomatic individualsG S Zubenko, H B Hughes, J S Stiffler
Molecular Psychiatry|July 10, 2001
Increased S100B blood levels in unmedicated and treated schizophrenic patients are correlated with negative symptomatologyM Rothermundt, U Missler, V Arolt, et al.
Molecular Psychiatry|July 10, 2001
Voltage-gated calcium channel gamma 2 subunit gene is not deleted in velo-cardio-facial syndromeJ L Black, L E Krahn, S M Jalal
Molecular Psychiatry|July 10, 2001
Borna disease virus-specific circulating immune complexes, antigenemia, and free antibodies--the key marker triplet determining infection and prevailing in severe mood disordersL Bode, P Reckwald, W E Severus, et al.
Molecular Psychiatry|March 13, 2001
Protein kinase A and Rap1 levels in platelets of untreated patients with major depressionJ Perez, D Tardito, G Racagni, et al.
Pageof 599